Vericel Corp. (VCEL)
40.32
+0.22
(+0.55%)
USD |
NASDAQ |
Oct 12, 14:13
Vericel Free Cash Flow (Quarterly) : 14.26M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.26M |
| March 31, 2026 | 15.13M |
| December 31, 2025 | 12.83M |
| September 30, 2025 | 19.45M |
| June 30, 2025 | 0.081M |
| March 31, 2025 | -7.612M |
| December 31, 2024 | 8.455M |
| September 30, 2024 | -9.225M |
| June 30, 2024 | 1.774M |
| March 31, 2024 | -6.815M |
| December 31, 2023 | 2.251M |
| September 30, 2023 | 0.60M |
| June 30, 2023 | 6.00M |
| March 31, 2023 | -1.053M |
| December 31, 2022 | 5.85M |
| September 30, 2022 | 1.616M |
| June 30, 2022 | 1.162M |
| March 31, 2022 | 0.387M |
| December 31, 2021 | 9.56M |
| September 30, 2021 | 1.171M |
| June 30, 2021 | 2.651M |
| March 31, 2021 | 7.743M |
| December 31, 2020 | 10.27M |
| September 30, 2020 | 4.20M |
| June 30, 2020 | -3.49M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.969M |
| December 31, 2019 | 2.789M |
| September 30, 2019 | 6.861M |
| June 30, 2019 | -19.37M |
| March 31, 2019 | -0.078M |
| December 31, 2018 | 2.034M |
| September 30, 2018 | 0.891M |
| June 30, 2018 | -6.236M |
| March 31, 2018 | 0.221M |
| December 31, 2017 | 0.116M |
| September 30, 2017 | -5.76M |
| June 30, 2017 | -5.857M |
| March 31, 2017 | -3.192M |
| December 31, 2016 | -9.409M |
| September 30, 2016 | -4.422M |
| June 30, 2016 | -6.194M |
| March 31, 2016 | -1.282M |
| December 31, 2015 | -4.134M |
| September 30, 2015 | -1.493M |
| June 30, 2015 | -5.68M |
| March 31, 2015 | -4.466M |
| December 31, 2014 | -6.991M |
| September 30, 2014 | -8.491M |
| June 30, 2014 | -6.083M |
| March 31, 2014 | -4.674M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| AbbVie, Inc. | 3.114B |
| ADMA Biologics, Inc. | 27.28M |
| Kyntra Bio, Inc. | -3.991M |
| Conexeu Sciences, Inc. | -6.800M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |